HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Claudia Ranucci Durante Selected Research

Chelating Agents

1/2021Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Claudia Ranucci Durante Research Topics

Disease

3Neoplasms (Cancer)
01/2024 - 01/2021
1Breast Neoplasms (Breast Cancer)
01/2024
1Prostatic Neoplasms (Prostate Cancer)
01/2023

Drug/Important Bio-Agent (IBA)

2RadiopharmaceuticalsIBA
01/2024 - 01/2023
1Peptide FragmentsIBA
01/2024
1Peptides (Polypeptides)IBA
01/2024
1tyrosyl-isoleucyl-glycyl-seryl-arginineIBA
01/2024
1LigandsIBA
01/2023
1AntigensIBA
01/2023
1Radioisotopes (Radionuclides)IBA
01/2023
1111In-DTPA-trastuzumabIBA
01/2021
1human ERBB2 proteinIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021
1Pentetic Acid (DTPA)FDA LinkGeneric
01/2021
1Chelating AgentsIBA
01/2021

Therapy/Procedure

1Therapeutics
01/2023